Logo image of BLMZ

BLOOMZ INC (BLMZ) Stock Fundamental Analysis

NASDAQ:BLMZ - Nasdaq - KYG1180K1168 - Currency: USD

0.4066  +0.01 (+1.65%)

After market: 0.4105 +0 (+0.96%)

Fundamental Rating

2

BLMZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 71 industry peers in the Entertainment industry. The financial health of BLMZ is average, but there are quite some concerns on its profitability. BLMZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BLMZ had negative earnings in the past year.
In the past year BLMZ had a positive cash flow from operations.
BLMZ Yearly Net Income VS EBIT VS OCF VS FCFBLMZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

With a Return On Assets value of -7.98%, BLMZ is not doing good in the industry: 65.15% of the companies in the same industry are doing better.
BLMZ has a Return On Equity (-16.26%) which is in line with its industry peers.
Industry RankSector Rank
ROA -7.98%
ROE -16.26%
ROIC N/A
ROA(3y)-3.12%
ROA(5y)N/A
ROE(3y)-11.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLMZ Yearly ROA, ROE, ROICBLMZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 10 -10 20 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 34.12%, BLMZ is doing worse than 68.18% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for BLMZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLMZ Yearly Profit, Operating, Gross MarginsBLMZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 10 -10 20 30

5

2. Health

2.1 Basic Checks

BLMZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
BLMZ has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, BLMZ has an improved debt to assets ratio.
BLMZ Yearly Shares OutstandingBLMZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
BLMZ Yearly Total Debt VS Total AssetsBLMZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M

2.2 Solvency

BLMZ has an Altman-Z score of 2.82. This is not the best score and indicates that BLMZ is in the grey zone with still only limited risk for bankruptcy at the moment.
BLMZ has a better Altman-Z score (2.82) than 80.30% of its industry peers.
BLMZ has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BLMZ (0.19) is better than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 2.82
ROIC/WACCN/A
WACC5.79%
BLMZ Yearly LT Debt VS Equity VS FCFBLMZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M -50M 100M 150M 200M

2.3 Liquidity

BLMZ has a Current Ratio of 1.60. This is a normal value and indicates that BLMZ is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.60, BLMZ is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
BLMZ has a Quick Ratio of 1.60. This is a normal value and indicates that BLMZ is financially healthy and should not expect problems in meeting its short term obligations.
BLMZ has a Quick ratio of 1.60. This is in the better half of the industry: BLMZ outperforms 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
BLMZ Yearly Current Assets VS Current LiabilitesBLMZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M 250M

0

3. Growth

3.1 Past

The earnings per share for BLMZ have decreased strongly by -6654.64% in the last year.
The Revenue for BLMZ has decreased by -11.75% in the past year. This is quite bad
EPS 1Y (TTM)-6654.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.01%
Revenue 1Y (TTM)-11.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%96.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLMZ Yearly Revenue VS EstimatesBLMZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 50M 100M
BLMZ Yearly EPS VS EstimatesBLMZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLMZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLMZ Price Earnings VS Forward Price EarningsBLMZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLMZ Per share dataBLMZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BLMZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLOOMZ INC

NASDAQ:BLMZ (2/21/2025, 8:03:45 PM)

After market: 0.4105 +0 (+0.96%)

0.4066

+0.01 (+1.65%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.8%
Inst Owner ChangeN/A
Ins Owners6.76%
Ins Owner ChangeN/A
Market Cap5.46M
AnalystsN/A
Price TargetN/A
Short Float %1.03%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.28
P/FCF N/A
P/OCF 65.86
P/B 3.9
P/tB 7.13
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.01
OCFY1.52%
SpS0.12
BVpS0.1
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.98%
ROE -16.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.12%
FCFM N/A
ROA(3y)-3.12%
ROA(5y)N/A
ROE(3y)-11.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 908.57%
Cap/Sales 39.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 2.82
F-Score6
WACC5.79%
ROIC/WACCN/A
Cap/Depr(3y)263.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.86%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6654.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.01%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%96.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-318.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-233.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-179.19%
OCF growth 3YN/A
OCF growth 5YN/A